Part Details | USP CIMETIDINE TABLETS
6505-01-103-6335
Alternate Parts: NDC60951063070, NDC60951-0630-70, TAGAMET TABLETS, TAGAMET, NDC00108501220, NDC00108-5012-20, NDC00378005301, NDC00378-0053-01, NDC55953018140, NDC55953-0181-40, NDC00781144701, NDC00781-1447-01, NDC00364259101, NDC00364-2591-01, 6505-01-103-6335, 01-103-6335, 6505011036335, 011036335
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | NOV 16, 1980 | 01-103-6335 | 36685 ( CIMETIDINE TABLETS, USP ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-103-6335
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC60951-0630-70 | 1DBS1 | ENDO PHARMACEUTICALS, INC.DBA VINTAGE PHARMACEUTICALS |
| TAGAMET TABLETS | 93544 | GLAXOSMITHKLINE HOLDINGS AMERICASINC. |
| TAGAMET | 93544 | GLAXOSMITHKLINE HOLDINGS AMERICASINC. |
| NDC00108-5012-20 | 93544 | GLAXOSMITHKLINE HOLDINGS AMERICASINC. |
| NDC00378-0053-01 | 60895 | MYLAN PHARMACEUTICALS INC |
| NDC55953-0181-40 | 0U3G2 | NOVOPHARM USA INC |
| NDC00781-1447-01 | 0THL4 | SANDOZ INC. |
| NDC00364-2591-01 | 0PTT8 | SCHEIN PHARMACEUTICAL INC |
Technical Data | NSN 6505-01-103-6335
| Characteristic | Specifications |
|---|---|
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | AB200.000 MILLIGRAMS CIMETIDINE |
| ADMINISTRATION | ORAL |
| PRIMARY CONTAINER TYPE | BOTTLE |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | CIMETDINE TABLETS 200MG 100S |